ReviewBMJ global health2017
Institutionalising health technology assessment: establishing the Medical Technology Assessment Board in India.
Review in BMJ global health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 1 synthesis or guideline pooled it.
- National Methodological Guidelines to Conduct Budget Impact Analysis for Health Technology Assessment in India.Applied health economics and health policy · 2021Pooled it
- Regulatory and HTA framework for herbal medicines in Indonesia.Journal of pharmaceutical policy and practice · 2026Review
- A Mixed-Methods Assessment of India's Health Technology Assessment Ecosystem.Applied health economics and health policy · 2026Article
- A systematic assessment of the demand for HTA hub services in Asia.International journal of technology assessment in health care · 2025Review
- Challenges in adopting health technology assessment for evidence-based policy in Iran: a qualitative study.Journal of health, population, and nutrition · 2025Article
- Mapping of health technology assessment in China: a comparative study between 2016 and 2021.Global health research and policy · 2024Article
- Health technology assessment (HTA) readiness in Uganda: stakeholder's perceptions on the potential application of HTA to support national universal health coverage efforts.International journal of technology assessment in health care · 2023Article
- Evaluation of EuroQol Valuation Technology (EQ-VT) Designs to Generate National Value Sets: Learnings from the Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study.Medical decision making : an international journal of the Society for Medical Decision Making · 2023Article
- Cost of screening, out-of-pocket expenditure & quality of life for diabetes & hypertension in India.The Indian journal of medical research · 2023Article
- Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India.BMC health services research · 2023Article
- How Least Developed to Lower-Middle Income Countries Use Health Technology Assessment: A Scoping Review.Pathogens and global health · 2023Article
- Article
- A comprehensive roadmap for MedTech innovations uptake into the public healthcare system in India.Frontiers in digital health · 2023Article
- Universal health coverage in India and health technology assessment: current status and the way forward.Frontiers in public health · 2023Article
- Health technology assessment implementation in WHO South-East Asia Region: a realist review protocol.Wellcome open research · 2023Article
- Cost of hospital services in India: a multi-site study to inform provider payment rates and Health Technology Assessment.BMC health services research · 2022Article
- Cost-effectiveness analysis of 'test and treat' policy for antiretroviral therapy among heterosexual HIV population in India.The Indian journal of medical research · 2022Article
- Cost Effectiveness of Bevacizumab Plus Chemotherapy for the Treatment of Advanced and Metastatic Cervical Cancer in India-A Model-Based Economic Analysis.JCO global oncology · 2022Article
- Cost effectiveness of typhoid vaccination in India.Vaccine · 2021Article
- Cost-Effectiveness of Temozolamide for Treatment of Glioblastoma Multiforme in India.JCO global oncology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
India is at crossroads with a commitment by the government to universal health coverage (UHC), driving efficiency and tackling waste across the public healthcare sector. Health technology assessment (HTA) is an important policy reform that can assist policy-makers to tackle inequities and inefficiencies by improving the way in which health resources are allocated towards cost-effective, appropriate and feasible interventions. The equitable and efficient distribution of health budget resources, as well as timely uptake of good value technologies, are critical to strengthen the Indian healthcare system. The government of India is set to establish a Medical Technology Assessment Board to evaluate existing and new health technologies in India, assist choices between comparable technologies for adoption by the healthcare system and improve the way in which priorities for health are set. This initiative aims to introduce a more transparent, inclusive, fair and evidence-based process by which decisions regarding the allocation of health resources are made in India towards the ultimate goal of UHC. In this analysis article, we report on plans and progress of the government of India for the institutionalisation of HTA in the country. Where India is home to one-sixth of the global population, improving the health services that the population receives will have a resounding impact not only for India but also for global health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.